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Abstract
Purpose: Axenfeld-Rieger syndrome (ARS) is a rare autosomal dominant disorder 
that affects the anterior segment of the eye. The aim of this study was to examine the 
PITX2 gene to identify possible novel mutations in Pakistani and Mexican families 
affected by the ARS phenotype.
Methods: Three unrelated probands with a diagnosis of ARS were recruited for this 
study. Genomic DNA was isolated from the peripheral blood of the probands and 
their family members. Polymerase chain reaction and Sanger sequencing were used 
for the analysis of coding exons and the flanking intronic regions of the PITX2 gene. 
Bioinformatics tools and database (VarSome, Provean, and MutationTaster, SIFT, 
PolyPhen-2, and HOPE) were evaluated to explore missense variants.
Results: We identified novel heterozygous variations in the PITX2 gene 
that segregated with the ARS phenotype within the families. The vari-
ant NM_153426.2(PITX2):c.226G  >  T or p.(Ala76Ser) and the mutation 
NM_153426.2(PITX2):c.455G  >  A or p.(Cys152Tyr) were identified in two 
Pakistani pedigrees, and the mutation NM_153426.2(PITX2):c.242_265del or 
p.(Lys81_Gln88del), segregated in a Mexican family.
Conclusion: Our study extends the spectrum of PITX2 mutations in individuals with 
ARS, enabling an improved diagnosis of this rare but serious syndrome.
K E Y W O R D S
anterior segment dysgenesis, Axenfeld-Rieger, mutations, PITX2
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1 |  INTRODUCTION
Abnormal development of the anterior segment of the eye, 
which includes the cornea, iris, lens, ciliary body, trabec-
ular meshwork, and Schlemm canal, is clinically defined 
as anterior segment dysgenesis disorder (ASD; OMIM 
107,250). ASD shows different clinical presentation, and 
many subtypes have been described, including aniridia-like 
phenotype, iris hypoplasia, Peters anomaly, Axenfeld-
Rieger syndrome (ARS; OMIM 180,500), Axenfeld and 
Rieger anomalies, and iridogoniodysgenesis. ARS is 
considered a rare syndrome, as it shows a prevalence of 
1/200,000 individuals, and it includes a phenotypically 
heterogeneous group of disorders, where ocular develop-
mental anomalies affect the cornea, iris, lens, and ante-
rior chamber angle. Specifically, the major clinical ocular 
phenotypes in patients affected by this syndrome include 
posterior embryotoxon, iridocorneal adhesions, iris stromal 
hypoplasia, corectopia, polycoria, and ectropion uveae. 
The nonocular systemic defects associated with ARS in-
clude dental (e.g., hypodontia, microdontia), craniofacial 
malformations (e.g., hypertelorism, prominent forehead, 
telecanthus), redundant periumbilical skin, and umbilical 
hernia (Idrees, Vaideanu, Fraser, Sowden, & Khaw, 2006; 
Intarak et al., 2018; Reis et al., 2012; Weisschuh, De Baere, 
Wissinger, & Tümer, 2011). Patients with this condition 
often have increased intraocular pressure (IOP) especially 
during childhood, and elevated IOP is associated with an 
increased risk of developing glaucoma. This is triggered 
by alterations of the iridocorneal angle drainage, causing 
an abnormal flow of the intraocular fluid through the ante-
rior segment and leading to glaucoma (Protas et al., 2017; 
Strungaru, Hermina Strungaru, Dinu, & Walter, 2007; 
Tanwar, Dada, Axenfeld-Rieger, & Associated, 2010).
ARS is inherited in an autosomal dominant manner and 
has complete penetrance. Two loci have been reported to be 
associated with ARS at the chromosome regions of 4q25 for 
the gene Pituitary Homeobox 2 (PITX2, OMIM 601,542) 
and 6p25 for the gene encoding Forkhead Box C1 (FOXC1, 
OMIM 601,090). While mutations in the PITX2 gene are 
more likely associated with ocular, dental, and umbilical 
anomalies, mutations in FOXC1 appear to be more correlated 
with isolated ocular or ocular, heart, and/or hearing defects 
(D'haene et al., 2011; Hjalt & Semina, 2005; Strungaru et al., 
2007).
Numerous heterozygous missense and nonsense muta-
tions, as well as deletions and duplications, have recently 
been identified among the two developmental transcription 
factor genes, especially in Caucasian populations (Alward, 
2000; Brooks et al., 2004; Seifi & Walter, 2018a; Titheradge 
et al., 2014; Tümer & Bach-Holm, 2009; Vieira et al., 2006; 
Zhang et al., 2019). In non-Caucasian patients with ARS 
from Mexico, mutations in the PITX2 genes have already 
been reported in the literature (Hernández-Martínez et al., 
2018).
The purpose of this study was to identify the causal mu-
tations in the PITX2 gene in patients affected with ARS, in 
Pakistani and Mexican families.
2 |  MATERIALS AND METHODS
2.1 | Subjects
Ethical approval for this study was obtained from the ethical 
committee of the Institutional Review Board of the Pediatric 
Glaucoma Department of Al-Shifa Trust Eye Hospitals in 
Rawalpindi (Pakistan) and the Genetics Department of the 
Association to prevent blindness in Mexico (Mexico). This 
study was performed in compliance with the Declaration of 
Helsinki. Written informed consent was obtained from all pa-
tients and their parents. Unrelated probands and their family 
members affected by ARS from Pakistan and Mexico were 
included in this study. Complete ophthalmologic examina-
tions were performed in all individuals. For visualization of 
the optic disk, biomicroscopy via slit lamp was used, whereas 
for the iridocorneal angle, gonioscopy was performed. 
Measurements of visual acuity and IOP were also collected. 
Applanation tonometry was used to measure IOP.
2.2 | Genetic Screening
Genomic DNA of probands and their family members 
was extracted from EDTA blood samples using a QIAamp 
DNA Blood Midi Kit (Qiagen, Hilden, Germany). Primers 
flanking the entire coding sequence were designed using 
the Primer Designing Tool Primer 3 of NCBI, available at 
https://www.ncbi.nlm.nih.gov/tools /prime r-blast / and used 
for the genetic analysis of PITX2 (the sets of primers are 
available in Appendix 1). Polymerase chain reaction (PCR) 
was conducted on the coding exons and exon/intron junc-
tions of the PITX2 gene. Direct DNA sequencing of PITX2 
PCR products was performed using ABI BigDye chemistry 
(Applied Biosystems Inc., Foster City, CA, USA) and the 
ABI 3,730 Sequencer (Applied Biosystems, Inc.). DNA se-
quencing results were aligned against the gene reference se-
quence of PITX2 (NM_153426.2). The alignment with the 
reference was made using CodonCode Aligner (version 6.1) 
(CodonCode Co., Centerville, MA, USA), and to identify 
pathogenic mutations, we queried the Genome Aggregation 
Database (gnomAD) (http://gnomad.broad insti tute.org/).
Alamut Visual (alamut.inter activ e-bioso ftware.com, ver-
sion 2.7.1, 2015) was used for the annotation and prediction 
of the functional impact of the identified variants at both 
the genomic and protein levels. Alamut® Visual comprises 
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many missense variant pathogenicity prediction tools and al-
gorithms, such as Sorting Intolerant From Tolerant (SIFT) 
and Polymorphism Phenotyping (PolyPhen-2). Additionally, 
MutationTaster, VarSome, DEOGEN2, EIGEN, PrimateAI, 
Provean, HOPE, the Grantham score and PhyloP scores were 
consulted and evaluated to establish the effect of changed 
nucleotide and amino acids (Flanagan, Patch, & Ellard, 
2010; Kopanos et al., 2019; Venselaar, te Beek, Kuipers, 
Hekkelman, & Vriend, 2010).
3 |  RESULTS
Brief details of variants and phenotypic features of patients 
identified in our study are summarized in Table 1.
The proband (II:1), from Pakistani family 1, was a 
14-year-old male patient with ARS. He was initially diag-
nosed with glaucoma and underwent a trabeculectomy to 
control IOP. The initial IOP of his right and left eye were 
45 and 34 mmHg, respectively. His visual acuity in the right 
eye was restricted to counting fingers. He also had corectopia 
and corneal opacity, both bilateral. His father and younger 
brother also had glaucoma with high IOP, polycoria, and cor-
neal edema. Systemic examination of all three affected in-
dividuals of the family showed typical ARS features, such 
as telecanthus, a thin upper lip, a lower protruding lip, and 
dental anomalies. In all the affected members, the protuber-
ant umbilicus was present.
Sequence analysis of the PITX2 gene in the proband 
revealed a heterozygous missense variant NM_153426.2 
(PITX2):c.226G  >  T or p.(Ala76Ser), genomic position 
4:111,542,484(C  >  A), segregating with the ARS pheno-
type within the family (Figure  1). The unaffected mother 
(I:2) has a normal DNA sequence. The PhyloP score for this 
particular variant was 0.76 and the amino acid conserva-
tion was corroborated by the Grantham distance of 99. This 
variant is absent in the publicly available GnomAD exomes 
and GnomAD genomes. For in silico analysis (DEOGEN2, 
EIGEN, MutationTaster, PrimateAI, Provean, and SIFT) the 
variant is predicted to be polymorphic, and according to the 
HOPE program, the mutant residue is larger and less hydro-
phobic than the wild-type residue, but was not able to desta-
bilize the protein functionality.
In family 2, the proband (II:1) was an 11-year-old male 
patient from Mexico. His clinical history showed that he 
had photophobia since birth, and he was initially diagnosed 
with congenital glaucoma. He received medical treatment for 
glaucoma until the age of 4 when a trabeculectomy was per-
formed on both eyes. He also had umbilical surgery at the 
age of 6 months. His best-corrected visual acuity for the right 
eye was 20/40, and for the left eye, light perception only. The 
IOP for the right eye was 18  mmHg, and for the left eye, 
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showed corneal opacity, a posterior embryotoxon, corectopia, 
ectropion uveae, and an irregular iris. The left eye was larger 
than the right eye, presenting with a generalized corneal 
opacity with edema and vascularization. Systemic examina-
tion showed facial dysmorphism, flattening of the mid-face, 
thin superior lip, microdontia, and absence of some teeth. His 
mother (I:2) had posterior embryotoxon in both eyes, iris hy-
poplasia in the right eye, polycoria in the left eye, and long 
iris processes at the anterior chamber angle in both eyes. No 
protuberant umbilicus was evaluated.
The proband was found to be heterozygous for the 
in-frame deletion pathogenetic variant NM_153426.2 
(PITX2):c.242_265del or p.(Lys81_Gln88del), starting from 
the genomic position 4:111,542,445 in the PITX2 gene. 
Segregation analysis revealed that this particular patho-
genetic variant was inherited from the affected mother 
(I:2) (Figure  2). In silico analysis (VarSome, Provean, and 
MutationTaster) of the pathogenetic variant predicted it to 
be disease causing and deleterious. The identified pathoge-
netic variant is absent in the GnomAD exomes and GnomAD 
genomes.
Family 3 was from Pakistan, comprising the proband and 
her affected sister and father. The proband (II:1) was diag-
nosed with an ARS phenotype with anterior segment abnor-
malities (polycoria, corectopia, posterior embryotoxon) and 
glaucoma with high IOP (36 and 48 mmHg for the right and 
the left eye, respectively). All three affected individuals had 
a protuberant umbilicus and abnormal dentition. A novel 
heterozygous missense pathogenetic variant c.455G > A or 
p(.Cys152Tyr), genomic position 4:111539780C  >  T, was 
identified in the proband (II:1) by direct DNA sequenc-
ing (Figure  3). This pathogenetic variant segregated with 
the disease phenotype in the affected younger sister (II:2) 
and their father (I:1). This particular pathogenetic variant, 
NM_153426.2(PITX2):c.455G  >  A or p.(Cys152Tyr), is 
considered by SIFT to be deleterious, by Polyphen-2 to be 
damaging, and by MutationTaster to be disease causing. The 
PhyloP score was 2.796, and the Grantham distance was 194, 
indicating nucleotide and amino acid conservation. The tools 
show that the cysteine amino acid is conserved among differ-
ent species (Figure 3). Another in silico analysis of the patho-
genetic variant predicts it to be disease causing (DEOGEN2, 
F I G U R E  1  Family 1 from Pakistan with ARS. (a) Pedigree showing the segregation of the variant NM_153426.2(PITX2):c.226G > T or 
p.(Ala76Ser) in Pakistani family in the PITX2 gene. The arrow indicates the proband. (b) Sequencing chromatogram of reverse sequence of PITX2 
for the homozygous wild-type and heterozygous carrier, with alanine replaced with serotonin in the affected member. (c) Conservation analysis of 
the proteins surrounding the variant p.(Ala76Ser) in various species
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EIGEN, MutationTaster, PrimateAI, Provean, and SIFT). 
The identified variant was absent in GnomAD exomes and 
GnomAD genomes. According to the HOPE prediction, the 
mutant residue is larger, leading to bumps. The hydrophobic-
ity of the wild-type and mutant residue differs, so the hydro-
phobic interactions, either in the core of the protein or on the 
surface, are lost.
4 |  DISCUSSION
In this study, we reported three novel heterozygous variations 
in the PITX2 gene segregating in three pedigrees with ARS 
from Pakistan and Mexico. Bioinformatics tools were used to 
identify these variations: NM_153426.2(PITX2):c.226G > T 
or p.(Ala76Ser), NM_153426.2(PITX2):c.242_265del or 
p.(Lys81_Gln88del), and NM_153426.2(PITX2):c.455G > A, 
or p.(Cys152Tyr).
The first identified variant is missense and located near 
the homeodomain region in the PITX2 protein; the second 
is a pathogenetic variant resulting in an in-frame deletion 
of seven-conserved amino acids in the homeodomain, and 
the third mutation affects the coding region at 3' to the ho-
meobox. The three identified novel variations are absent in 
GnomAD Browser. To the best of our knowledge, the vari-
ations in PITX2 identified in this study have not previously 
been reported (Tümer & Bach-Holm, 2009).
The PITX2 gene, located on 4q25, encodes proteins in-
volved in the regulation of procollagen lysyl hydroxylase 
and a transcription factor of the paired-like homeodomain 
family, which plays an important role in the development 
of eyes, heart, brain, limb, umbilicus, and teeth. Many of 
these tissues are derived from neural crest cells, implying 
that some of the clinical features of ARS are probably due 
to a failure of the migration and differentiation processes 
during embryonic development. Consequently, pathogenic 
changes in PITX2 gene cause defects in the development 
of the abovementioned tissues. Specifically, for the eye, 
PITX2 mutations are associated with a vast range of eye 
diseases, such as ARS, Peters anomaly, iris hypoplasia, 
aniridia, and ring dermoid (Evans & Gage, 2005; Footz, 
Idrees, Acharya, Kozlowski, & Walter, 2009). Moreover, 
F I G U R E  2  Family 2 from Mexico with ARS. (a) Pedigree showing the segregation of the deletion NM_153426.2(PITX2):c.242_265del or 
p.(Lys81_Gln88del). The arrow indicates the proband. (b) Sequencing chromatogram reverse sequence of PITX2 showing the region of loss of 
the seven codons in affected heterozygous members and marked in red in the DNA sequence. (c) Multiple sequence alignment of PITX2 region 
surrounding the mutation p.(Lys81_Gln88del) in orthologous species
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patients affected by ARS show a higher risk of developing 
glaucoma during their lifetime. The expected risk can be 
estimated to be approximately 50%, which highlights the 
urgency of developing effective prevention actions, espe-
cially in countries where access to the health care system 
can still represent a challenge (Cella et al., 2006; Idrees 
et al., 2006).
The PITX2 gene encodes multiple protein isoforms that 
have different N-termini according to their roles during de-
velopment. In contrast, the C-terminus shows an identical 
sequence of DNA, resulting in a highly conserved region. 
PITX2 presents two conserved regions: the homeobox and the 
Orthopedia Aristaless and Rax (OAR) domains. The homeo-
box encodes a 60-amino acid conserved homeodomain, as-
suring the functionality of the gene, the localization of PITX2 
into the nucleus, the DNA binding, and the protein–protein 
interaction. Similarly, the OAR domain, located within the 
C-terminus, mediates the protein–protein interactions as well 
as the self-inhibitory interactions with the N-terminus. The 
homeodomain recognizes the bicoid motive of promoters of 
genes involved in tooth differentiation, such as DLX2. Thus, 
mutations in the PITX2 gene are likely to be associated with 
dental anomalies (Datson et al., 1996; Semina et al., 1996).
Usually, mutations in PITX2 involved in ARS can show 
variability in terms of expressions of the phenotype regard-
ing the ocular anterior segment abnormalities, even within 
families carrying the same variant (Kamińska, Sokołowska-
Oracz, Pawluczyk-Dyjecińska, & Szaflik, 2007; Tümer & 
Bach-Holm, 2009). In the families that we investigated, the 
affected members showed a similar manifestation of the 
syndrome.
Most of the alterations reported in the literature on the 
PITX2 gene are point mutations, such as missense, nonsense, 
and splice-site recognition, lying in the homeodomain and 
C-terminal region of the protein. The point mutations could 
act via a loss-of-function or gain-of-function mechanism 
causing dysfunction in the DNA binding process and in 
transcriptional transactivation (Brooks et al., 2004; Phillips, 
2002; Seifi et al., 2016; Tümer & Bach-Holm, 2009).
Studying genotype–phenotype correlations in this syn-
drome is challenging since there is not a direct correlation 
between the position of the mutation and the severity of the 
F I G U R E  3  Family 3 from Pakistan with ARS. (a) Pedigree showing the segregation of the mutation NM_153426.2(PITX2):c.455G > A 
or p.(Cys152Tyr) in the PITX2 gene. The arrow indicates the proband. (b) Sequencing chromatogram of the forward sequence of the wild-type 
fragment of the DNA in unaffected individual and heterozygous sequence in the affected individual. (c) Multiple sequence alignment of PITX2 
region surrounding the mutation p.(Cys152Tyr) in various species
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ARS manifestation. Previous studies showed that the severity 
of this syndrome can be directly correlated with the resid-
ual function retained by the Pitx2 protein, which depends on 
the effect that the mutant allele exerts. Functional analysis 
showed that PITX2 mutations can have a gain-of-function ef-
fect or diminish the capacity to bind DNA and act as a tran-
scription and transactivation factor. Specifically, mutations 
with a hypomorphic allele are able to retain some function-
alities. For example, these mutations can still transactivate 
genes like DLX2, which is important for tooth development, 
and the patients that carry them do not report dental malfor-
mations. On the other hand, patients carrying a gain-of-func-
tion mutation in the PITX2 gene can present ARS with tooth 
anomalies, due to the inability to transactivate the DLX2 pro-
moter (Espinoza, Cox, Semina, & Amendt, 2002; Kozlowski 
& Walter, 2000; Saadi et al., 2006; Tümer & Bach-Holm, 
2009).
Currently, bioinformatics tools show a high predictive 
value in estimating the potential pathogenicity and alteration 
effects of missense variants in PITX2. In particular, the sen-
sitivity and specificity were demonstrated to be > 93% (Seifi 
& Walter, 2018b). In silico analysis performed for the hetero-
zygous missense variant reported in our study, p.(Ala76Ser), 
predicted it to be polymorphic, meaning that this variant does 
not destabilize the PITX2 product.
A number of studies have reported that PITX2 proteins 
can create homodimeric aggregates. This mechanism was 
suggested to explain the dominant-negative model associated 
with mutations in patients with ARS. In fact, it is import-
ant that the dosage of PITX2 expression is well regulated 
because variations (increase or decrease) of its product can 
impair the regulation of other genes involved in its pathway 
(Maciolek, Alward, Murray, Semina, & McNally, 2006; 
Priston et al., 2001; Saadi, Kuburas, Engle, & Russo, 2003; 
Saadi et al., 2001). The heterozygous pathogenetic variant, 
p.(Lys81_Gln88del) is the first in-frame deletion reported 
in the literature that involves seven amino acids located in 
the homeodomain region. It could exert its effects through 
binding with other PITX2 interactors, presumably producing 
heterodimers instead of homodimers, via a dominant-nega-
tive effect. However, as an in-frame deletion, the stability and 
functionality of the products might vary.
The PITX2 gene exerts its effect on transactivation through 
the C-terminus region, which shows both an inhibitory and 
a stimulatory function. Footz et al. ascertained that muta-
tions located in the proximal inhibitory domain might carry 
out their pathogenic effects altering the transactivation pro-
cess (Footz et al., 2009). Similarly, the pathogenetic variant 
identified in this report, p.(Cys152Tyr), located in the HD-
proximal inhibitory domain of the C-terminus, might change 
the affinity of PITX2 binding with the other interactors in 
a cell-specific context, and cause altered responsiveness to 
them.
In addition to previously reported cases of ARS that were 
caused by deletion variants in the PITX2 gene in Caucasian 
populations, our study identified an in-frame deletion vari-
ant responsible for the syndrome. However, this variant does 
not seem to produce a different clinical manifestation to the 
ones extensively investigated in Caucasian patients in other 
studies. Furthermore, the novel variants identified in the 
Pakistani families with ARS confirm the pathogenetic role of 
the PITX2 gene in relation to this syndrome (Micheal et al., 
2016).
In conclusion, we investigated the segregation of three 
newly discovered variants in affected and unaffected fam-
ily members of Mexican and Pakistani patients, using bio-
informatics tools to ascertain their pathogenic role in ARS 
syndrome. Our study extends the range of PITX2 variants in 
individuals with ARS, leading to an improved diagnosis of 
this syndrome.
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